Metro Health

Name

Metro Health

Website

https://yhxhealth.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Metro Health is a Suzhou, China-based private AI company focused on the medical and science sectors, founded in 2014, operating with 11–50 employees, and led by founder and CEO Zoey Zhiyao Wang.

Ownership category

akta.pro rank

Headquarters

HQ city

Suzhou

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Core offering

Metro Health is an artificial intelligence company focused on the medical and science sectors. It develops AI-driven products and capabilities intended to serve healthcare and scientific organizations. Public details on specific productized offerings are limited in the available source material.

Differentiator

Problem solved

Functional benefit

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Brisbane South PHNcoreStrategic or Co-development PartnerMetro South Health and Brisbane South PHN co-hosted a 'Building Better Health Together' workshop in late 2024, bringing together GPs and health service executives to improve collaboration across six clinical areas. The workshop aimed to strengthen communication and care coordination between community and hospital providers.

Broad incumbents

• Yitu Technology: Shanghai-based AI platform with healthcare applications among its verticals. Comparable as a more broadly-funded incumbent operating in the same AI-in-medical space in China.
• Ping An Healthcare and Technology: Ping An's healthcare arm combining telemedicine with AI-driven health services. Comparable as a large, capital-rich incumbent selling AI-enabled healthcare services to Chinese consumers and providers.
• Alibaba Health Information Technology: Alibaba-affiliated healthcare platform investing in AI and healthcare data infrastructure. Comparable as a large incumbent in the China healthcare-AI ecosystem with capital and distribution advantages.
• Tencent Miying: Tencent's medical AI platform for imaging and clinical decision support. Comparable as a deep-pocketed incumbent tackling AI in Chinese healthcare at scale.

Direct peers

• WeDoctor: Chinese digital health and telemedicine platform. Comparable as a Chinese healthcare digital platform with AI-enabled services serving a similar customer base.
• Voxelcloud: Medical imaging AI startup with roots in China and operations in the US. Comparable as a focused AI-in-medical company with cross-border ambitions and a similar early-stage commercialization profile.
• Infervision: Beijing-based medical imaging AI company serving Chinese hospitals. Directly comparable to a Suzhou-based AI company targeting the medical sector with hospital-grade tooling.
• iCarbonX: Shenzhen-based AI health-data platform. Comparable as a China-based AI company focused on life sciences and health data, similarly navigating early-stage commercialization.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metro Health